ImpediMed

ImpediMed Inventory Turnover

The Inventory Turnover Ratio of ImpediMed (IPD.AX) as of Oct 20, 2026 is 11.99. In the previous year, Inventory Turnover Ratio was 2.03 — a change of 490.07% (higher).

Inventory Turnover

11.99

YoY

490.07%

Last updated:

Inventory Turnover Ratio of ImpediMed is 2026 11.99 . Inventory Turnover Ratio of ImpediMed was 2025 2.03 . It decreases by 490.07% higher compared to the previous year.

The ImpediMed Inventory Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory Turnover
Date
Inventory Turnover
Jan 1, 2019
1.12 AUD
Jan 1, 2020
21.56 AUD
Jan 1, 2021
55.41 AUD
Jan 1, 2022
25.83 AUD
Jan 1, 2023
30.86 AUD
Jan 1, 2024
1.73 AUD
Jan 1, 2025
2.03 AUD
Jan 1, 2026
11.99 AUD
The ImpediMed Inventory Turnover history
YEARInventory TurnoverYoY
11.99+490.07%
2.03+17.34%
1.73-94.39%
30.86+19.49%
25.83-53.39%
55.41+156.97%
21.56+1,830.53%
1.12+107.24%
0.54-46.98%
1.02-11.52%
1.15+42.12%
0.81-5.48%
0.86—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ImpediMed Stock analysis

What does ImpediMed do? ImpediMed Ltd is an Australian company specializing in medical devices and technologies. They were founded in 1999 and have their headquarters in Brisbane, Australia. The company is a leading provider of bioimpedance measurement devices for the diagnosis, monitoring, and treatment of lymphatic, cardiac, and other medical conditions. They have a wide range of products used in various medical fields, including oncology, lymphology, and cardiology. Their main business model is based on the development and marketing of their bioimpedance measurement devices. They also provide training and support for medical personnel to optimize the use of their devices. ImpediMed specializes in the diagnosis and treatment of lymphedema in the oncology sector, particularly using their highly precise L-Dex® device. They also analyze body composition in the cardiology sector to determine the risk of heart diseases and develop personalized treatment approaches. In recent years, ImpediMed has expanded into the European market, particularly in lymphedema diagnosis and treatment. Overall, ImpediMed Ltd is an innovative company that focuses on medical devices and technologies for the diagnosis and monitoring of cardiac and lymphatic diseases. They provide important diagnostic capabilities to medical professionals and continue to focus on growth and expansion. ImpediMed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImpediMed stock

Inventory Turnover Ratio of ImpediMed is 11.99 in 2026.

Inventory Turnover Ratio of ImpediMed changed from 2.03 to 11.99, representing a 490.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Turnover Ratio ImpediMed since 2006 – with annual values, charts, and detailed analysis.

Inventory turnover measures how many times inventory is sold and replaced during a period. Higher turnover indicates efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Inventory Turnover Ratio's ImpediMed with sector peers and the industry average to assess whether it is attractive.

To evaluate Inventory Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Inventory Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ImpediMed

All Key Metrics — ImpediMed